Episode 64

Bridging to Transplant for HCC

with Dr. Jennifer Berumen and Dr. Isabel Newton

BackTable, LLC (Producer). (2020, May 21). Ep. 64 – Bridging to Transplant for HCC [Audio podcast]. Retrieved from https://www.backtable.com/podcasts

Transplant Surgeon Dr. Jennifer Berumen and Interventional Radiologist Dr. Isabel Newton discuss the treatment of HCC and the importance of multi-specialty collaboration in bridging these patients to successful liver transplantation. Special discussion was given around this HCC consortium article in Annals of Surgery: https://pubmed.ncbi.nlm.nih.gov/30870180/

Special thanks to our sponsor

Podcast Participants

Dr. Jennifer Berumen

Dr. Jennifer Berumen is a transplant surgeon and assistant professor with the UCSD Department of Surgery in San Diego.

Dr. Isabel Newton

Dr. Isabel Newton is a practicing interventional radiologist at UC San Diego Health in San Diego, CA.

Dr. Christopher Beck

Host Dr. Christopher Beck is a practicing interventional radiologist with Regional Radiology Group in New Orleans.

TriSalus Infusion Systems

TriSalus Life Sciences is dedicated to improving patient outcomes in HCC and other highly intractable solid tumors. TriSalus Infusion Systems have the potential to deliver diagnostic, therapeutic, and immuno-stimulant agents directly into the tumor vascular, powered by their proprietary pressure-enabled delivery approach.

TriSalus Life Sciences Sponsorship on BackTable

Show Notes

• Milan Criteria:
https://www.mdcalc.com/milan-criteria-liver-transplantation

• NCCN Guidelines:
https://www.nccn.org/about/news/ebulletin/ebulletindetail.aspx?ebulletinid=667

• Criteria for Liver Transplantation in Hepatocellular Carcinoma:
https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/cld.499

• The Interventional Initiative:
http://www.theii.org/

• Paper discussed:
DiNorcia J, Florman SS, Haydel B, et al. Pathologic Response to Pretransplant Locoregional
Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular
Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Ann Surg.
2020;271(4):616‐624. doi:10.1097/SLA.0000000000003253

Learn more:

Transcript Preview

This transcript is not yet available.

Join The Discussion

Related Content

No related content.

i-video.png

Podcast

Pressure-Directed Therapy in TACE

Pressure-Directed Therapy in TACE Podcast Guest Dr. Justin Lee
i-video.png

Podcast

Targeting the Tumor Microenvironment in HCC

Targeting the Tumor Microenvironment in HCC BackTable Podcast Guest Dr. Terence Gade
i-video.png

Practice Tool

Child-Pugh Score Calculator

Child-Pugh Score Calculator on BackTable
i-video.png

Article

TACE Versus Radioablation in the Treatment of Hepatocellular Carcinoma (HCC)

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

 
TriSalus Infusion System on BackTable

Submit this form to get in touch with a rep and learn more about treating solid tumors with TriSalus Infusion Systems.

Thanks! Message sent.

TriSalus Infusion System on BackTable
BackTABLEfinal-2tone_edited.png

© 2021 by Backtable. All rights reserved.